| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
10,632 |
7,066 |
$480K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
346 |
290 |
$24K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
263 |
217 |
$13K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,151 |
923 |
$6K |
| 36415 |
Collection of venous blood by venipuncture |
806 |
693 |
$2K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
37 |
28 |
$923.43 |
| 81002 |
|
561 |
456 |
$830.85 |
| 82962 |
|
130 |
101 |
$80.55 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
146 |
132 |
$22.80 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
62 |
55 |
$19.24 |
| 3725F |
|
141 |
131 |
$0.00 |
| 1160F |
|
30 |
27 |
$0.00 |
| 1159F |
|
30 |
27 |
$0.00 |
| 3078F |
|
34 |
34 |
$0.00 |
| 3077F |
|
14 |
13 |
$0.00 |
| 3079F |
|
28 |
27 |
$0.00 |
| 3008F |
|
170 |
153 |
$0.00 |
| 1125F |
|
30 |
28 |
$0.00 |
| 1126F |
|
44 |
42 |
$0.00 |
| 3074F |
|
33 |
32 |
$0.00 |